Weight Management Program (WMP)

OTHER2 trials

Sponsors

Novo Nordisk A/S, The Cleveland Clinic

Conditions

ObesityType 2 Diabetes

Phase 4

Real World Effectiveness of Combining an Employer-based Weight Management Program With Medication for Chronic Weight Management in Employees With Obesity

CompletedNCT03799198

Novo Nordisk A/SObesity

Start: 2019-01-07End: 2020-05-22Updated: 2022-11-14

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

TerminatedNCT04531176

The Cleveland ClinicObesity, Type 2 Diabetes

Start: 2020-09-01End: 2023-08-04Updated: 2024-09-19

Related Papers

An Obesity-Centric Approach with and Without Anti-Obesity Medications Compared to the Usual-Care Approach to Management of Patients with Obesity and Type 2 Diabetes in an Employer Setting: A Pragmatic Randomized Controlled Trial (EMPOWER-T2D).

2024-04-041 citations

Effectiveness of Combining Antiobesity Medication With an Employer-Based Weight Management Program for Treatment of Obesity

JAMA Network Open2021-07-1326 citations